• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药效团映射和计算机模拟筛选以鉴定新型强效A(2A)腺苷受体拮抗剂先导化合物。

Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.

作者信息

Mustyala Kiran Kumar, Chitturi Annapurna Renee, Naikal James Prameela Subhashini, Vuruputuri Uma

机构信息

Department of Chemistry, Nizam College, Osmania University, Basheerbagh, Hyderabad, Andhra Pradesh, India.

出版信息

J Recept Signal Transduct Res. 2012 Apr;32(2):102-13. doi: 10.3109/10799893.2012.660532. Epub 2012 Mar 2.

DOI:10.3109/10799893.2012.660532
PMID:22384789
Abstract

A(2A) adenosine receptor (AR) antagonists play an important role in neurodegenerative diseases like Parkinson's disease. A 3D-QSAR study of A(2A) AR antagonists, was taken up to design best pharmacophore model. The pharmacophoric features (ADHRR) containing a hydrogen bond acceptor (A), a hydrogen bond donor (D), a hydrophobic group (H) and two aromatic rings (R), is projected as the best predictive pharmacophore model. The QSAR model was further treated as a template for in silico search of databases to identify new scaffolds. The binding patterns of the leads with A(2A) AR are analysed using docking studies and novel potent ligands of A(2A) AR are projected.

摘要

A(2A)腺苷受体(AR)拮抗剂在帕金森病等神经退行性疾病中发挥着重要作用。开展了一项关于A(2A)AR拮抗剂的3D-QSAR研究,以设计最佳药效团模型。包含氢键受体(A)、氢键供体(D)、疏水基团(H)和两个芳香环(R)的药效特征(ADHRR)被预测为最佳预测药效团模型。该QSAR模型进一步用作数据库虚拟搜索的模板,以识别新的支架。通过对接研究分析先导化合物与A(2A)AR的结合模式,并预测A(2A)AR的新型强效配体。

相似文献

1
Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.药效团映射和计算机模拟筛选以鉴定新型强效A(2A)腺苷受体拮抗剂先导化合物。
J Recept Signal Transduct Res. 2012 Apr;32(2):102-13. doi: 10.3109/10799893.2012.660532. Epub 2012 Mar 2.
2
First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.CCR3 受体拮抗剂的首个药效基团模型及其同源模建辅助的逐步虚拟筛选。
Chem Biol Drug Des. 2011 May;77(5):373-87. doi: 10.1111/j.1747-0285.2011.01088.x. Epub 2011 Mar 1.
3
Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.基于药效团的筛选和 3D-QSAR 方法在新型 JAK2 抑制剂发现中的应用
J Mol Graph Model. 2011 Sep;30:186-97. doi: 10.1016/j.jmgm.2011.07.004. Epub 2011 Jul 22.
4
3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.选择性A2A和A2B腺苷受体拮抗剂的3D药效团模型
J Chem Inf Model. 2007 Mar-Apr;47(2):613-25. doi: 10.1021/ci600410m. Epub 2007 Mar 2.
5
Molecular docking study of A(3) adenosine receptor antagonists and pharmacophore-based drug design.A(3) 腺苷受体拮抗剂的分子对接研究及基于药效团的药物设计
Neurochem Int. 2009 Dec;55(7):637-42. doi: 10.1016/j.neuint.2009.06.006. Epub 2009 Jun 18.
6
3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
Acta Pol Pharm. 2012 Jul-Aug;69(4):763-72.
7
Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening.基于药效团和 3D-QSAR 的计算机筛选探索新型支架作为潜在的 MAO-A 抑制剂。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2419-24. doi: 10.1016/j.bmcl.2011.02.072. Epub 2011 Feb 19.
8
Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.重新审视基于受体的药效基团假设在人类 A(2A) 腺苷受体拮抗剂中的作用。
J Chem Inf Model. 2013 Jul 22;53(7):1620-37. doi: 10.1021/ci300615u. Epub 2013 Jun 20.
9
Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.基于片段的 A(2A) 腺苷受体先导化合物发现中计算筛选和生物物理筛选方法的互补性。
J Chem Inf Model. 2013 Oct 28;53(10):2701-14. doi: 10.1021/ci4003156. Epub 2013 Sep 18.
10
Discovery of potent adenosine A2a antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling.发现强效的腺苷 A2a 拮抗剂作为潜在的抗帕金森病药物。非线性 QSAR 分析与药效团建模相结合。
Chem Biol Interact. 2016 Jul 25;254:93-101. doi: 10.1016/j.cbi.2016.05.023. Epub 2016 May 20.

引用本文的文献

1
The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.基于药效团的 3D-QSAR 建模与虚拟筛选在安全性分析中的整合:以鉴定对腺苷受体 A2A 具有拮抗活性的 1897 种已知药物为例的研究
PLoS One. 2019 Jan 3;14(1):e0204378. doi: 10.1371/journal.pone.0204378. eCollection 2019.
2
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.针对帕金森病药物研究的 G 蛋白偶联受体的计算机研究。
Curr Neuropharmacol. 2018;16(6):786-848. doi: 10.2174/1570159X16666180308161642.